Peking Union Medical College Hospital
Beijing, Beijing, China
ZHANG Lifan has 15 years of study and research experience in infectious diseases and clinical epidemiology, dedicated to the clinical and basic research of tuberculosis. As well as the top-level design of clinical studies, the design, construction and management of large observational studies/cohort studies, data analysis, and the evaluation and interpretation of research evidence. Lifan has published more than 50 original papers, reviews and book chapters.
Main publications：
1. Zhang L, Yang Z, Bao X, Ma H, Ge Q, Zhang Y, et al. Comparison of diagnostic accuracy of QuantiFERON-TB Gold Plus and T-SPOT.TB in the diagnosis of active tuberculosis in febrile patients. J Evid Based Med 2022; 15(2):97-105.
2. Zhang L, Wan S, Zhou Z, Zhang Y, Liu X. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study. BMC Infect Dis 2021; 21(1):651.
3. Zhang L, Ma H, Wan S, Zhang Y, Gao M, Liu X. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection. Chin Med J (Engl) 2021; 135(1):63-69.
4. Liu X, Zhang L, Zhang F, Zeng X, Zhao Y, Wang Q, et al. Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China. Emerg Microbes Infect 2021; 10(1):2303-2312.
Disclosure information not submitted.
Sunday, November 13, 2022
1:00 PM – 3:00 PM Eastern Time
